According to documents from the Hong Kong Stock Exchange, Zhengxiang Pharmaceutical (Nanjing) Group Co., Ltd.-B has submitted a listing application to the Hong Kong Stock Exchange, with China International Capital Corporation (CICC) as the sole sponsor.